450 filings
Page 10 of 23
8-K
6650wina
15 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
kt90exx rfi2f4b
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
kc8ye79rubvji s2
18 Apr 19
Entry into a Material Definitive Agreement
6:05am
8-K
5w4nzqxls z78t
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
DEFA14A
23h ymcxvp
28 Mar 19
Additional proxy soliciting materials
12:46pm
8-K
vkof4 kzt
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
pktcphli6str 91a
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm
EFFECT
k4tap a33f
22 Mar 19
Notice of effectiveness
12:16am
DEFA14A
emx2gslypy8ve7wj
21 Mar 19
Additional proxy soliciting materials
12:00am
CORRESP
tzmzsx
20 Mar 19
Correspondence with SEC
12:00am
CT ORDER
agis ukrzaihz
18 Mar 19
Confidential treatment order
2:44pm
CT ORDER
frfkjh3 k7mu6
7 Mar 19
Confidential treatment order
1:22pm
8-K/A
18zmhq
6 Mar 19
Entry into a Material Definitive Agreement
5:02pm
CORRESP
8xayvz4224u1nx
6 Mar 19
Correspondence with SEC
12:00am
8-K
p6wxfzra
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
UPLOAD
xxql2glgpuxep9cm mc
4 Mar 19
Letter from SEC
12:00am
S-8
4m3pqm6662
19 Feb 19
Registration of securities for employees
4:07pm